Anti-Inflammatory Therapies for Atopic Dermatitis: A New Era in Targeted Treatment.

J Clin Med · 2025 · PMC12296171 · PMID 40725743

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

might not be significantno p-value reported

Itepekimab (REGN3500), another IL-33 inhibitor, also exhibited a lack of clinical efficacy [ 92 ], which indicates that the role of IL-33 in AD pathogenesis might not be significant. 6.2.4.

also in 673 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.